These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19014178)

  • 1. Review: rifaximin is equally or more effective than other antibiotics and lactulose for hepatic encephalopathy.
    Alcorn J
    ACP J Club; 2008 Nov; 149(5):11. PubMed ID: 19014178
    [No Abstract]   [Full Text] [Related]  

  • 2. Review: lactulose or lactitol may improve hepatic encephalopathy but may be less effective than antibiotics.
    Korula J
    ACP J Club; 2004; 141(3):59. PubMed ID: 15518443
    [No Abstract]   [Full Text] [Related]  

  • 3. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
    Sharma BC; Sharma P; Agrawal A; Sarin SK
    Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management options for minimal hepatic encephalopathy.
    Bajaj JS
    Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):785-90. PubMed ID: 19090738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut instinct: rifaximin for the prevention of hepatic encephalopathy.
    Siddique A; Kowdley K
    Hepatology; 2010 Aug; 52(2):792-4. PubMed ID: 20683970
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifaximin in hepatic encephalopathy: more than just a non-absorbable antibiotic?
    Jalan R
    J Hepatol; 2010 Sep; 53(3):580-2. PubMed ID: 20561708
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifaximin in hepatic encephalopathy: is an ounce of prevention worth a pretty penny?
    Leise MD; Kim WR
    Gastroenterology; 2010 Oct; 139(4):1416-8. PubMed ID: 20736020
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rifaximin treatment in hepatic encephalopathy].
    Gundling F; Schepp W
    Z Gastroenterol; 2011 Sep; 49(9):1345-6. PubMed ID: 21887667
    [No Abstract]   [Full Text] [Related]  

  • 10. The immunomodulatory effect of lactulose on Enterococcus faecium fed preruminant calves.
    Fleige S; Preissinger W; Meyer HH; Pfaffl MW
    J Anim Sci; 2009 May; 87(5):1731-8. PubMed ID: 19098237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of portal systemic encephalopathy: standard and new treatments.
    Marín E; Uribe M
    Rev Invest Clin; 1990 Jul; 42 Suppl():141-8. PubMed ID: 19256154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyponatremia in hepatic encephalopathy: an accomplice or innocent bystander?
    Yun BC; Kim WR
    Am J Gastroenterol; 2009 Jun; 104(6):1390-1. PubMed ID: 19455127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy.
    Hassanein T; Blei AT; Perry W; Hilsabeck R; Stange J; Larsen FS; Brown RS; Caldwell S; McGuire B; Nevens F; Fontana R
    Am J Gastroenterol; 2009 Jun; 104(6):1392-400. PubMed ID: 19455117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical observation on therapeutic effect of colon purification on hepatic encephalopathy].
    Zhao HP; Ding BH; Zhang JS; Guo SM; Zhang ZR; Zhao YZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):222-4. PubMed ID: 19031710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroinflammation contributes to hypokinesia in rats with hepatic encephalopathy: ibuprofen restores its motor activity.
    Cauli O; Rodrigo R; Piedrafita B; Llansola M; Mansouri MT; Felipo V
    J Neurosci Res; 2009 May; 87(6):1369-74. PubMed ID: 19025766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain GABA and benzodiazepine receptors in hepatic encephalopathy.
    Butterworth RF
    Rev Invest Clin; 1990 Jul; 42 Suppl():137-40. PubMed ID: 19256153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines.
    Randolph C; Hilsabeck R; Kato A; Kharbanda P; Li YY; Mapelli D; Ravdin LD; Romero-Gomez M; Stracciari A; Weissenborn K;
    Liver Int; 2009 May; 29(5):629-35. PubMed ID: 19302444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bifidogenic effect and stimulation of short chain fatty acid production in human faecal slurry cultures by oligosaccharides derived from lactose and lactulose.
    Cardelle-Cobas A; Fernández M; Salazar N; Martínez-Villaluenga C; Villamiel M; Ruas-Madiedo P; de los Reyes-Gavilán CG
    J Dairy Res; 2009 Aug; 76(3):317-25. PubMed ID: 19450367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the local applications of antibiotics and antibiotic-based agents in endodontics and dental traumatology.
    Mohammadi Z; Abbott PV
    Int Endod J; 2009 Jul; 42(7):555-67. PubMed ID: 19467048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental models of hepatic encephalopathy: ISHEN guidelines.
    Butterworth RF; Norenberg MD; Felipo V; Ferenci P; Albrecht J; Blei AT;
    Liver Int; 2009 Jul; 29(6):783-8. PubMed ID: 19638106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.